期刊文献+

丝裂霉素、白细胞介素Ⅱ联合治疗恶性胸腔积液40例疗效分析 被引量:3

下载PDF
导出
摘要 目的观察丝裂霉素白细胞介素Ⅱ(IL-2)联合治疗恶性胸腔积液的临床疗效。方法将40例恶性胸腔积液患者随机分组治疗组22例及对照组18例,两组患者在胸腔闭式引流放净胸水后,治疗组胸腔内注射丝裂霉素IL-2,对照组注射丝裂霉素。结果治疗组完全缓解(CR)11例,部分缓解(PR)9例,总有效率90%,对照组CR6例,PR7例,总有效率66%,两组比较差异显著性(P<0.05)。结论丝裂霉素IL-2联合治疗恶性胸腔积液疗效确切,毒副作用小,疗效满意。
作者 张树明
出处 《中国实用医药》 2010年第10期130-131,共2页 China Practical Medicine
  • 相关文献

参考文献3

二级参考文献11

  • 1Light RW. Pleural effusion. N Engl J Med 2002,346(25):1971~1977.
  • 2Romero-Candeira S, Hernandez L, Romero-Brufao S et al. Is It Meaningful To Use BiochemicalParameters To Discriminate Between Transudative and Exudative Pleural Effusions? Chest.2002; 122:1524~ 1529.
  • 3Aoe K,Hiraki A,Murakami T,et al. Diagnostic significance of Interferon-γ in tuberculous pleural effusions. Chest 2003, 123:740~744.
  • 4Putnam, JB Jr. Malignant Pleural Effusions. Surgical Clinics of North America 2002;82(4) :867~883.
  • 5Yang CT,Lee MH,Lau RS,et al. Telomerase acitivity in pleural effusion :diagnostic significance. J Clin Oncol 1998,16 : 567~ 573.
  • 6Ferrer, J, Villarino, MA, Encabo, G, et al. Diagnostic utility of CYFRA21 - 1 ,carcinoembryonic antigen,CA 125, neuron specific enolase,and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions. Cancer 1999,86,1488~ 1495.
  • 7Antunes G,Neville E, Duffy J,et al. BTS guidelines for the management of malignant pleural effusion. Thorax, 2003; 58 (Suppl Ⅱ ) :ii29~ii38.
  • 8Fer rer J,Villarion MA,Tura JM,et al. Talc preparations used for pleurodesis vary markedly from one preparation to another.Chest 2001; 119:1901~5.
  • 9Milanez de Campos JR, Vargas FS, Werebe EC,et al. Thoracoscopy talc poudrage. A 15-year experience. Chest 2001; 119:801~6.
  • 10桂淑玉,汪渊,刘虎,周青.癌性胸水p16基因纯合性缺失检测的临床意义[J].癌症,2000,19(3):253-255. 被引量:5

共引文献97

同被引文献20

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部